| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $166.0M | +0.5% |
| Cost of Revenue | $56.5M | -2.9% |
| Gross Profit | $109.5M | +2.4% |
| R&D Expense | $19.7M | -25.4% |
| SG&A Expense | $139.8M | -4.0% |
| Operating Income | -$50.0M | +23.1% |
| Pre-tax Income | -$84.6M | -7.7% |
| Income Tax | -$32K | +60.5% |
| Net Income | -$84.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.3M | +125.7% |
| Accounts Receivable | $65.0M | +38.5% |
| Inventory | $78.8M | -0.9% |
| Current Assets | $243.0M | +39.0% |
| Total Assets | $346.8M | +29.1% |
| Current Liabilities | $68.3M | +19.5% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.5M | +33.9% |
| Capital Expenditures | $6.1M | -22.7% |
| Investing Cash Flow | -$15.6M | +36.4% |
| Financing Cash Flow | $125.9M | +46.0% |
| Free Cash Flow | -$64.6M | +33.0% |
| -7.8% |
| EPS (Basic) | -$3.00 | +2.3% |
| EPS (Diluted) | -$3.00 | +2.3% |
| Total Liabilities |
| $293.7M |
| +17.4% |
| Stockholders' Equity | $53.1M | +188.6% |